Laboratory Reference Grade Compounds

B7-33 / Relaxin-2 Receptor Mimetic (10mg Research Vial)

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱5,200.00
Out of stock
Net Content10MG
InclusionVial Only
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (10MG)
Diluent:mL
Concentration10.00 mg/mLin 1.0mL BAC
Standard Dose500 mcg – 1,000 mcg daily research exposureSyringe: 10.0 IU = 500 mcg at 5.0 mg/mL
Scale (1 Unit)100 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
B7-33 / Relaxin-2 Receptor Mimetic (10mg Research Vial)10MG · Vial Only
₱5,200.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

B7-33 is a synthetic 33-amino-acid single-chain functional peptide mimetic derived from the B-chain of human relaxin-2. Unlike native relaxin-2, which signals through both classical and oncogenic pathways, B7-33 selectively activates the RXFP1 receptor to stimulate cyclic AMP and extracellular signal-regulated kinase (pERK) phosphorylation without promoting cell proliferation. This targeted mechanism drives potent anti-fibrotic, vasodilatory, and tissue remodeling actions across cardiac, pulmonary, and renal preclinical models.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryTissue Repair & Healing
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number2165322-26-9
PubChem CID16132338↗
Molecular Weight3012.56 g/mol
Purity Specification≥99.0% (RP-HPLC)
Net Content Options2MG, 10MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaVIKLSGRELVRAQIAISGMSTWSKRSL